Ikaria Bioscience Pty Ltd

This early-stage trial tests a new drug called RN5681 in 60 healthy adults to see if it is safe and how the body handles it. Participants receive either a single injection of RN5681 or a placebo. The study also looks at how the drug affects cholesterol levels, but the main focus …

This early-stage trial tests a new drug called RN3161, alone and combined with the weight-loss drug tirzepatide, in 104 adults with overweight or obesity. The main goals are to check safety and how the body handles the drug. Researchers will also measure weight changes. The study…